Switching from paliperidone palmitate 3-monthly long-acting injection to oral aripiprazole in a pregnant woman with schizophrenia: a case report and short review

Riv Psichiatr. 2024 Mar-Apr;59(2):75-79. doi: 10.1708/4259.42361.


Treatment with long-acting injection (LAI) antipsychotics, such as paliperidone palmitate, has improved the quality of life in terms of symptoms and prevention of relapses in patients with schizophrenia. Although there are plenty of evidences about the efficacy and safety of paliperidone palmitate 3-monthly injection (PP3M) in adults with schizophrenia, literature appears lacking about the use of LAIs during pregnancy. We hereby describe the clinical case of a pregnant woman affected by schizophrenia (DSM-5-TR), taking pharmacological treatment of PP3M. Considering the inadequate evidence regarding the use of PP3M in pregnancy in agreement with the patient, we switched PP3M to an oral therapy with aripiprazole. The switch to oral aripiprazole allowed the patient to improve her sense of autonomy and strengthen the therapeutic relationship. To our knowledge, this is the first case report monitoring an entire pregnancy of a women affected by schizophrenia in treatment with PP3M injection and oral aripiprazole. No obstetrical or fetal complications were reported. As the research in this field is very demanding, it would be precipitous to derive final conclusions from the current case report, but we hope to build a growing number of data that would allow us to make more appropriate and safe therapeutic choices in such a vulnerable phase as the peripartum.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Administration, Oral
  • Adult
  • Antipsychotic Agents* / administration & dosage
  • Antipsychotic Agents* / therapeutic use
  • Aripiprazole* / administration & dosage
  • Aripiprazole* / therapeutic use
  • Delayed-Action Preparations*
  • Drug Substitution
  • Female
  • Humans
  • Injections, Intramuscular
  • Paliperidone Palmitate* / administration & dosage
  • Paliperidone Palmitate* / therapeutic use
  • Pregnancy
  • Pregnancy Complications* / drug therapy
  • Schizophrenia* / drug therapy


  • Aripiprazole
  • Paliperidone Palmitate
  • Antipsychotic Agents
  • Delayed-Action Preparations